PubRank

Therese B Bevers

Author PubWeight™ 45.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006 11.22
2 Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 2005 7.70
3 Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer. Cancer Prev Res (Phila) 2010 5.81
4 NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw 2009 2.78
5 Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol 2005 2.17
6 Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene. J Clin Oncol 2009 1.54
7 Prognostic role of detection method and its relationship with tumor biomarkers in breast cancer: the university of Texas M.D. Anderson Cancer Center experience. Cancer Epidemiol Biomarkers Prev 2008 1.12
8 Breast Cancer Risk Reduction, Version 2.2015. J Natl Compr Canc Netw 2015 1.12
9 Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer. Cancer Prev Res (Phila) 2012 1.01
10 Are there racial differences in breast cancer treatments and clinical outcomes for women treated at M.D. Anderson Cancer Center? Breast Cancer Res Treat 2006 0.98
11 Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia. Clin Cancer Res 2002 0.89
12 Breast cancer risk reduction. J Natl Compr Canc Netw 2010 0.88
13 Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition. J Womens Health (Larchmt) 2010 0.88
14 Chemoprevention for Breast Cancer. Ann Surg Oncol 2015 0.83
15 Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 years. Breast Cancer Res Treat 2007 0.83
16 Exemestane in the prevention setting. Ther Adv Med Oncol 2012 0.79
17 A human papillomavirus testing system in women with abnormal Pap results: a comparison study with follow-up biopsies. Acta Cytol 2007 0.78
18 Ultrasound for the screening of breast cancer. Curr Oncol Rep 2008 0.78
19 Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision. Clin Breast Cancer 2013 0.78
20 Brain responses to erotic and other emotional stimuli in breast cancer survivors with and without distress about low sexual desire: a preliminary fMRI study. Brain Imaging Behav 2013 0.76
21 Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting. Cancer Med 2014 0.76
22 An Antibody-based Blood Test Utilizing a Panel of Biomarkers as a New Method for Improved Breast Cancer Diagnosis. Biomark Cancer 2013 0.76
23 CT screening for lung cancer. Curr Oncol Rep 2007 0.75
24 Physical Activity Algorithm In A Comprehensive Cancer Center.: 1879 Board #31 June 2, 3: 30 PM - 5: 00 PM. Med Sci Sports Exerc 2016 0.75
25 The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results. Cancer Cytopathol 2012 0.75
26 Breast cancer risk reduction therapy: the low-hanging fruit. J Natl Compr Canc Netw 2015 0.75